Logo (Merck) 351 (Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base))
Generic Name: vorapaxar
Pill imprint Logo (Merck) 351 has been identified as Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base).
Zontivity is used in the treatment of peripheral arterial disease; thromboembolic disorder; prevention of atherothrombotic events and belongs to the drug class protease-activated receptor-1 antagonists. There is no proven risk in humans during pregnancy. Zontivity vorapaxar sulfate 2.5 mg (2.08 mg base) is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo (Merck) 351
- vorapaxar sulfate 2.5 mg (2.08 mg base)
- Elliptical / Oval
- Prescription only
- Drug Class:
- Protease-activated receptor-1 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Merck Sharp & Dohme Corp.
More about Zontivity (vorapaxar)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: protease-activated receptor-1 antagonists
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.